Gauteng reports alarming HIV prevalence among 50-54-year-olds
Gauteng's HIV prevalence peaks at 32.2% among residents aged 50-54, reveals a new HSRC survey. ART coverage rises to 73.4%, but awareness gaps remain.
Aspen Pharmacare to boost medicine and vaccine development
Aspen secures €500m loan from IFC-led consortium to boost Africa’s medicine and vaccine production, continuing its mission to strengthen local pharmaceutical capacity.
AfroCentric reports mixed results amid strategic investments
AfroCentric posts mixed annual results with a 74.9% profit drop due to impairments, but higher headline earnings signal a recovery in SA's pharmaceutical sector.
AIDS & TB: Lessons from the past, challenges for the future
South Africa's fight against AIDS and TB spotlights battles over high drug costs, patent monopolies, and the power of activism in securing affordable medicines for all.
Group urges clarification on cover for autoimmune diseases
The Autoimmune Association of South Africa (AASA) calls for the Council for Medical Schemes (CMS) to issue clear guidance on medical schemes’ obligations to cover costly specialised treatments for autoimmune diseases amidst growing patient disputes.